Metraipolis › archive › dc_e36ec2efd6fc

Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe — Europe PMC PMID:41157619

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41157619
DOI: 10.3390/v17101348
License (as archived): solo-consultazione
Archived: 2026-11-09T12:13:23.221Z
SHA-256 of the archived text: 5918bea42dba04642b47ff87f6318c22e8202de277b0ee7cce99e832c5bbf47e
Stable URL of this page: https://metraipolis.com/documento/dc_e36ec2efd6fc

How to cite

Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe — Europe PMC PMID:41157619 — Europe PMC (en), https://europepmc.org/article/MED/41157619 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e36ec2efd6fc (Metraipolis archive dc_e36ec2efd6fc, sha256 5918bea42dba04642b47ff87f6318c22e8202de277b0ee7cce99e832c5bbf47e)

BibTeX

@misc{dce36ec2efd6fc,
  title = {Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe — Europe PMC PMID:41157619},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41157619},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e36ec2efd6fc; sha256 5918bea42dba04642b47ff87f6318c22e8202de277b0ee7cce99e832c5bbf47e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41157619. Agents can read the archived copy with the MCP tool read_document.